Pazopanib for the treatment of soft-tissue sarcoma

Pazopanib is a multikinase inhibitor which potently inhibits the activity of major receptor tyrosine kinases, including vascular endothelial growth factor receptor-1, vascular endothelial growth factor receptor-2, vascular endothelial growth factor receptor-3, platelet-derived growth factor receptor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Heudel, Pierre, Cassier, Philippe, Derbel, Olfa, Dufresne, Armelle, Meeus, Pierre, Thiesse, Philippe, Ranchère-Vince, Dominique, Blay, Jean Yves, Ray-Coquard, Isabelle
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2012
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3508654/
https://ncbi.nlm.nih.gov/pubmed/23204874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S33195
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados